Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Effects of budlein A on human neutrophils and lymphocytes

Full text
Author(s):
Knob, Carollinie Dias ; da Silva, Milena ; Gasparoto, Thais Helena ; de Oliveira, Carine Ervolino ; Amor, Nadia Ghinelli ; Arakawa, Nilton Syogo ; da Costa, Fernando Batista ; Campanelli, Ana Paula
Total Authors: 8
Document type: Journal article
Source: Journal of Applied Oral Science; v. 24, n. 3, p. 271-277, MAY-JUN 2016.
Web of Science Citations: 3
Abstract

ABSTRACT Sesquiterpene lactones (SLs) are the active constituents of a variety of medicinal plants used in traditional medicine for the treatment of inflammatory diseases and other ailments. Objective In this study, we evaluated whether budlein A modulates the activation of innate and adaptive immune cells such as neutrophils and lymphocytes. Material and Methods Our research group has investigated several plant species and several compounds have been isolated, identified, and their medical potential evaluated. Budlein A is a SL isolated from the species Aldama buddlejiformis and A. robusta (Asteraceae) and shows anti-inflammatory and anti-nociceptive activities. Advances in understanding how plant-derived substances modulate the activation of innate and adaptive immune cells have led to the development of new therapies for human diseases. Results Budlein A inhibited MPO activity, IL-6, CXCL8, IL-10, and IL-12 production and induces neutrophil apoptosis. In contrast, budlein A inhibited lymphocyte proliferation and IL-2, IL-10, TGF-β, and IFN-γ production, but it did not lead to cell death. Conclusions Collectively, our results indicate that budlein A shows distinct immunomodulatory effects on immune cells. (AU)

FAPESP's process: 08/03931-7 - Study of Budleína A as inhibitors of human neutrophil
Grantee:Milena da Silva
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 08/09554-0 - Study of Budleína A as inhibitors of human lymphocytes
Grantee:Carollinie Dias Knob
Support Opportunities: Scholarships in Brazil - Scientific Initiation